Novo Nordisk and Eli Lilly potentially Risking Consumer Health with Ozempic and Mounjaro

Companies that produce drugs with potentially serious side effects have a duty to warn consumers about those side effects. This duty to consumers exists so that, when we’re making critical decisions about our health and our bodies, we have the information we need to make the best choice. 

At Shub & Johns, we’re alarmed by allegations that Novo Nordisk and Eli Lilly did not adequately warn consumers of the side effects of Ozempic and Mounjaro. Have you taken Ozempic or Mounjaro and experienced side effects? If so, we’d like to hear from you. Please complete the contact form on this page or contact us at 610-477-8380 or [email protected].